AAAAAA
Results: 1-25/31
Authors:
Pittet, MJ
Speiser, DE
Valmori, D
Rimoldi, D
Lienard, D
Lejeune, F
Cerottini, JC
Romero, P
Citation: Mj. Pittet et al., Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients, INT IMMUNO, 1(7), 2001, pp. 1235-1247
Authors:
Pittet, MJ
Speiser, DE
Lienard, D
Valmori, D
Guillaume, P
Dutoit, V
Rimoldi, D
Lejeune, F
Cerottini, JC
Romero, P
Citation: Mj. Pittet et al., Expansion and functional maturation of human tumor antigen-specific CD8(+)T cells after vaccination with antigenic peptide, CLIN CANC R, 7(3), 2001, pp. 796S-803S
Authors:
Vouillamoz-Lorenz, S
Bauer, J
Lejeune, F
Decosterd, LA
Citation: S. Vouillamoz-lorenz et al., Validation of an AAS method for the determination of platinum in biological fluids from patients receiving the oral platinum derivative JM216, J PHARM B, 25(3-4), 2001, pp. 465-475
Authors:
Brand, M
Moggs, JG
Oulad-Abdelghani, M
Lejeune, F
Dilworth, FJ
Stevenin, J
Almouzni, G
Tora, L
Citation: M. Brand et al., UV-damaged DNA-binding protein in the TFTC complex links DNA damage recognition to nucleosome acetylation, EMBO J, 20(12), 2001, pp. 3187-3196
Authors:
Rubio-Godoy, V
Dutoit, V
Rimoldi, D
Lienard, D
Lejeune, F
Speiser, D
Guillaume, P
Cerottini, JC
Romero, P
Valmori, D
Citation: V. Rubio-godoy et al., Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, P NAS US, 98(18), 2001, pp. 10302-10307
Authors:
Millan, MJ
Gobert, A
Lejeune, F
Newman-Tancredi, A
Rivet, JM
Auclair, A
Peglion, JL
Citation: Mj. Millan et al., S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine, J PHARM EXP, 298(2), 2001, pp. 565-580
Authors:
Millan, MJ
Cussac, D
Milligan, G
Carr, C
Audinot, V
Gobert, A
Lejeune, F
Rivet, JM
Brocco, M
Duqueyroix, D
Nicolas, JP
Boutin, JA
Newman-Tancredi, A
Citation: Mj. Millan et al., Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization, J PHARM EXP, 297(3), 2001, pp. 876-887
Authors:
Millan, MJ
Lejeune, F
De Nanteuil, G
Gobert, A
Citation: Mj. Millan et al., Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats, J NEUROCHEM, 76(6), 2001, pp. 1949-1954
Authors:
Pittet, MJ
Zippelius, A
Speiser, DE
Assenmacher, M
Guillaume, P
Valmori, D
Lienard, D
Lejeune, F
Cerottini, JC
Romero, P
Citation: Mj. Pittet et al., Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: Implicationsof a novel approach for T cell monitoring in infectious and malignant diseases, J IMMUNOL, 166(12), 2001, pp. 7634-7640
Authors:
Le Guienr, C
Lejeune, F
Galiana, D
Kister, L
Breathnach, R
Stevenin, J
Del Gatto-Konczak, F
Citation: C. Le Guienr et al., TIA-1 and TIAR activate splicing of alternative exons with weak 5 ' splicesites followed by a U-rich stretch on their own pre-mRNAs, J BIOL CHEM, 276(44), 2001, pp. 40638-40646
Authors:
Lejeune, F
Cavaloc, Y
Stevenin, J
Citation: F. Lejeune et al., Alternative splicing of intron 3 of the serine/arginine-rich protein 9G8 gene - Identification of flanking exonic splicing enhancers and involvement of 9G8 as a trans-acting factor, J BIOL CHEM, 276(11), 2001, pp. 7850-7858
Authors:
Ghanem, G
Loir, B
Morandini, R
Sales, F
Lienard, D
Eggermont, A
Lejeune, F
Citation: G. Ghanem et al., On the release and half-life of S100B protein in the peripheral blood of melanoma patients, INT J CANC, 94(4), 2001, pp. 586-590
Authors:
Speiser, DE
Migliaccio, M
Pittet, MJ
Valmori, D
Lienard, D
Lejeune, F
Reichenbach, P
Guillaume, P
Luscher, I
Cerottini, JC
Romero, P
Citation: De. Speiser et al., Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells, EUR J IMMUN, 31(2), 2001, pp. 459-466
Authors:
Lejeune, F
Millan, MJ
Citation: F. Lejeune et Mj. Millan, Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5-HT1A receptors, EUR J NEURO, 12(9), 2000, pp. 3265-3275
Authors:
Millan, MJ
Gobert, A
Rivet, JM
Adhumeau-Auclair, A
Cussac, D
Newman-Tancredi, A
Dekeyne, A
Nicolas, JP
Lejeune, F
Citation: Mj. Millan et al., Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram, EUR J NEURO, 12(3), 2000, pp. 1079-1095
Authors:
Gobert, A
Rivet, JM
Lejeune, F
Newman-Tancredi, A
Adhumeau-Auclair, A
Nicolas, JP
Cistarelli, L
Melon, C
Millan, MJ
Citation: A. Gobert et al., Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat, SYNAPSE, 36(3), 2000, pp. 205-221
Authors:
Millan, MJ
Newman-Tancredi, A
Audinot, V
Cussac, D
Lejeune, F
Nicolas, JP
Coge, F
Galizzi, JP
Boutin, JA
Rivet, JM
Dekeyne, A
Gobert, A
Citation: Mj. Millan et al., Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states, SYNAPSE, 35(2), 2000, pp. 79-95
Authors:
Millan, MJ
Lejeune, F
Gobert, A
Citation: Mj. Millan et al., Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents, J PSYCHOPH, 14(2), 2000, pp. 114-138
Authors:
Millan, MJ
Lejeune, F
Gobert, A
Brocco, M
Auclair, A
Bosc, C
Rivet, JM
Lacoste, JM
Cordi, A
Dekeyne, A
Citation: Mj. Millan et al., S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine, J PHARM EXP, 295(3), 2000, pp. 1206-1222
Authors:
Millan, MJ
Gobert, A
Newman-Tancredi, A
Lejeune, F
Cussac, D
Rivet, JM
Audinot, V
Dubuffet, T
Lavielle, G
Citation: Mj. Millan et al., S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626, J PHARM EXP, 293(3), 2000, pp. 1048-1062
Authors:
Millan, MJ
Gobert, A
Newman-Tancredi, A
Lejeune, F
Cussac, D
Rivet, JM
Audinot, V
Adhumeau, A
Brocco, M
Nicolas, JP
Boutin, JA
Despaux, N
Peglion, JL
Citation: Mj. Millan et al., S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile, J PHARM EXP, 292(1), 2000, pp. 38-53
Authors:
Rimoldi, D
Rubio-Godoy, V
Dutoit, V
Lienard, D
Salvi, S
Guillaume, P
Speiser, D
Stockert, E
Spagnoli, G
Servis, C
Cerottini, JC
Lejeune, F
Romero, P
Valmori, D
Citation: D. Rimoldi et al., Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma, J IMMUNOL, 165(12), 2000, pp. 7253-7261
Authors:
Valmori, D
Dutoit, V
Lienard, D
Lejeune, F
Speiser, D
Rimoldi, D
Cerundolo, V
Dietrich, PY
Cerottini, JC
Romero, P
Citation: D. Valmori et al., Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8(+) T cells in melanoma patients, J IMMUNOL, 165(1), 2000, pp. 533-538
Authors:
Valmori, D
Dutoit, V
Lienard, D
Rimoldi, D
Pittet, MJ
Champagne, P
Ellefsen, K
Sahin, U
Speiser, D
Lejeune, F
Cerottini, JC
Romero, P
Citation: D. Valmori et al., Naturally occurring human lymphocyte antigen-A2 restricted CD8+T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients, CANCER RES, 60(16), 2000, pp. 4499-4506
Authors:
Kettaneh, A
Fain, O
Ziol, M
Lejeune, F
Eclache-Saudreau, V
Biaggi, A
Guettier-Bouttier, C
Thomas, M
Citation: A. Kettaneh et al., Minocycline-induced systemic adverse reaction with liver and bone marrow granulomas and Sezary-like cells, AM J MED, 108(4), 2000, pp. 353-354